Search
01/07/2023
Cardiac amyloidosis and left atrial appendage closure. The CAMYLAAC study.
Amat-Santos IJ, Delgado-Arana JR, Cruz-González I, Gutiérrez H, García-Bolao I, Millán X, Tirado-Conte G, Ruiz-Nodar JM, Mohandes M, Palazuelos J, Torres Saura F, Del Valle R, Valero Picher E, Núñez García JC, Gómez I, Albarrán Rincón R, Arzamendi D, Nombela-Franco L, Korniiko L, Barrero A, Santos-Martínez S, Serrador A, San Román JA. Cardiac amyloidosis and left atrial appendage closure. The CAMYLAAC study.. REVISTA ESPANOLA DE CARDIOLOGIA. 2023; 76(7)DOI:10.1016/j.rec.2022.08.001. PMID:35934294. IF:(Q/D).
01/07/2023
Special Issue: New Insight into the Molecular Role of Lipids and Lipoproteins in Vascular Diseases
Benitez, S, Sanchez-Quesada, JL. Special Issue: New Insight into the Molecular Role of Lipids and Lipoproteins in Vascular Diseases. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13)DOI:10.3390/ijms241310659. PMID:37445837. IF:4.900(Q1/3D).
01/07/2023
Statins revisited: therapeutic applications beyond lipid lowering?
Badimon, L, Mendieta, G, Vilahur, G. Statins revisited: therapeutic applications beyond lipid lowering?. EUROPEAN HEART JOURNAL. 2023; 44(25)DOI:10.1093/eurheartj/ehad324. PMID:37316965. IF:38.100(Q1/1D).
01/07/2023
Connected Insulin Pens and Caps: An Expert's Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)
Tejera-Perez, C, Chico, A, Azriel-Mira, S, Lardies-Sanchez, B, Gomez-Peralta, F. Connected Insulin Pens and Caps: An Expert's Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN). Diabetes Therapy. 2023; 14(7)DOI:10.1007/s13300-023-01417-1. PMID:37188930. IF:2.800(Q3/6D).
01/07/2023
Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry
López-Oliva M.O., Pérez-Flores I., Molina M., José Aladrén M., Trujillo H., Redondo-Pachón D., López V., Facundo C., Villanego F., Rodríguez M., Carmen Ruiz M., Antón P., Rivas-Oural A., Cabello S., Portolés J., de la Vara L., Tabernero G., Valero R., Galeano C., Moral E., Ventura A., Coca A., Ángel Muñoz M., Hernández-Gallego R., Shabaka A., Ledesma G., Bouarich H., Ángeles Rodríguez M., Pérez Tamajón L., Cruzado L., Emilio Sánchez J., Jiménez C.. Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry. Nefrologia. 2023; 43(4)DOI:10.1016/j.nefroe.2023.08.004. PMID:37661514. IF:(Q/D).
01/07/2023
Impaired Regulation by IL-35 in Systemic Sclerosis
Osuna-Gomez, R, Castellvi, I, Mulet, M, Ortiz, MA, Brough, DE, Sabzevari, H, Semnani, RT, Vidal, S. Impaired Regulation by IL-35 in Systemic Sclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13)DOI:10.3390/ijms241310567. PMID:37445745. IF:4.900(Q1/3D).
01/07/2023
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry
Valcarcel, S, Gallego, J, Jimenez-Fonseca, P, Diez, M, de Castro, EM, Hernandez, R, Arrazubi, V, Custodio, A, Cano, JM, Montes, AF, Macias, I, Visa, L, Calvo, A, Tocino, RV, Lago, NM, Limon, ML, Granja, M, Gil, M, Pimentel, P, Macia-Rivas, L, Perez, CH, Mangas, M, Carnicero, AM, Cerda, P, Gonzalez, LG, Navalon, FG, Rambla, MDM, Richard, MM, Carmona-Bayonas, A. Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; 149(7)DOI:10.1007/s00432-022-04294-6. PMID:36042046. IF:2.700(Q3/6D).
01/07/2023
Association between the Immunophenotype of Peripheral Blood from mCRPC Patients and the Outcomes of Radium-223 Treatment
Canto, E, Anguera, G, Jimenez, N, Mellado, B, Ramirez, O, Mariscal, A, Maroto, P, Vidal, S. Association between the Immunophenotype of Peripheral Blood from mCRPC Patients and the Outcomes of Radium-223 Treatment. Diagnostics. 2023; 13(13)DOI:10.3390/diagnostics13132222. PMID:37443615. IF:3.000(Q1/2D).